Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Consumer Staples

BioHarvest Sciences Inc. (BHST)

NGM · Packaged Foods

$2.04+0.01 (+0.49%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$46.2M
P/E (TTM)
EPS
$-0.57
Div Yield
52W Range
$1.82–$12.80
Beta
1.38

Company overview

Next earnings: 2026-08-11(14d)

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.

Peers in Packaged Foods

All in industry →

Recent press releases

March 2026

4 months ago40-FConsumer Staples

BIOHARVEST SCIENCES INC. — 40-F Filing

BHSTBIOHARVEST SCIENCES INC.

# 🧾 What This Document Is This is BIOHARVEST SCIENCES INC.'s **Annual Information Form (AIF)**, filed as part of its 40-F annual report with the SEC. Think of it as a comprehensive "owner's manual" that publicly traded companies must update yearly. It details the company's business, risk factors, m

Read summaryView on SEC EDGAR

SEC filings

All filings →
1 recent filing shown in the timeline above. View all SEC filings →

BioHarvest Sciences Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
757,064 sh● NEW
34,928 sh-79.2%
139,470 sh● NEW
55,000 sh0.0%
40,000 sh● NEW
35,233 sh+5510.4%
33,275 sh● NEW
27,998 sh● NEW

People at BioHarvest Sciences Inc.

All people →

No officers or directors have been indexed for BioHarvest Sciences Inc..

Quarterly financials

Full financials →
Revenue trend
12/24
$25.2M
NI -$12.9M
RevenueNI = Net Income
EPS trend (diluted)
EPS history not available.